QGEN Qiagen NV

-0.07 (-0.18%)
Last Updated: 14:50:38
Delayed by 15 minutes

Register Free for Streaming Quotes & Tools

Register for Free to get streaming quotes, interactive charts, trades, portfolio, live options flow and more.


Draw Mode:

Volume 641,648
Bid Price
Ask Price
News -
Day High 39.85


52 Week Range


Day Low 39.24
Company Name Stock Ticker Symbol Market Type
Qiagen NV QGEN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.07 -0.18% 39.54 14:50:38
Open Price Low Price High Price Close Price Prev Close
39.60 39.24 39.85 39.61
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
8,562 641,648 $ 39.49 $ 25,336,031 - 38.98 - 51.18
Last Trade Time Type Quantity Stock Price Currency
14:51:00 1 $ 39.53 USD

Qiagen NV Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
9B 227.72M - 2.14B 575.66M 2.53 10.18
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Qiagen NV News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No QGEN Message Board. Create One! See More Posts on QGEN Message Board See More Message Board Posts

Historical QGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week40.3940.9738.9839.72978,352-0.85-2.1%
1 Month46.0446.2538.9841.751,218,644-6.50-14.12%
3 Months45.0747.7038.9844.121,267,456-5.53-12.27%
6 Months46.4147.7038.9844.761,100,056-6.87-14.8%
1 Year41.2251.1838.9845.43990,512-1.68-4.08%
3 Years52.4159.0038.9848.21882,471-12.87-24.56%
5 Years37.4359.0024.8042.861,155,0852.115.64%

Qiagen NV Description

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (45% of 2021 sales), followed by EMEA (36%) and Asia-Pacific (19%).